MALP-2S

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameMALP-2S

Drug Alias NameMALP-2S

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionToll like receptor 6 agonistsToll like receptor 2 agonists

TargetsToll like receptor 6Toll like receptor 2

Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesMbiotec Gmbh

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesMbiotec Gmbh

Active IndicationsN/A

Inactive IndicationsCarcinoma, Non-Small-Cell LungPancreatic Neoplasms

ATC CodeN/A